Return to our Home Page


Technical Resources
Technical Information
Calbiochem Information
Interactive Pathways
Alzheimer's Disease
Alzheimer's Disease Related Products - GSK-3
 
Alzheimer's Home
Alzheimer's Interactive Pathway™
Alzheimer's Brain Tissue Sections
a-Secretase
b-Amyloid
b-Secretase
g-Secretase
Tau
GSK-3
Acetylcholinesterase
Cyclooxygenase
Glycogen Synthase Kinase-3b (GSK-3b; tau protein kinase I), a highly conserved, ubiquitously expressed serine/threonine protein kinase is involved in the signal transduction cascades of multiple cellular processes. It is negatively regulated by protein kinase B/Akt and by the Wnt signaling pathway. Higher levels of GSK-3b have been shown in pre-tangle and in phosphorylated tau bearing neurons. Overexpression of GSK-3b is a characteristic feature of Alzheimer’s disease. GSK-3b accounts for most major phosphorylation sites of fetal and paired helical filament-tau. b-Amyloid peptides are shown to activate GSK-3b, suggesting that activation of GSK-3b is a key mechanism in the pathogenesis of Alzheimer’s disease. The development of GSK-3 inhibitors holds considerable promise for reducing tau phosphorylation and the debilitating effects of Alzheimer’s disease.
 
GSK-3 Antibodies
 
GSK-3 Inhibitors
 
GSK-3 Enzymes
 
GSK-3 Substrates